Ad  RAD Intel

The Company Fixing Ads Isn't Public Yet – But Insiders Are Investing

You've seen them. The cringey, mistargeted, and downright WTF ads. You sit there wondering why brands are spending billions on content that just leaves you questioning your entire algorithmic existence after seeing it.

RAD Intel is teaching brands - with proprietary tech - how to read the room. Their AI helps brands understand why content works, who it actually resonates with, and what to say next. RAD analyzes real-time audience behavior and predicts what will convert, so brands can stop guessing and start making ads that actually land.

And it's already in serious demand. Fortune 1000 brands like Hasbro, Sweetgreen, Skechers, and MGM are using RAD Intel to level up their marketing - and getting up to 3.5x better results. With $37M+ raised and a valuation that's jumped from $5M to $85M*, it's a bit of a shock that RAD Intel is still pre-IPO. Shares are just $0.60, and investors from Meta, Google, Amazon, and Fidelity Ventures are already in.

So check them out now and get in on the action before then, lest you get stuck in the "I almost invested" cycle of regret.

👉 Click here to secure your shares


DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai.

UnitedHealth raises concerns over Bill Ackman’s post on X with SEC

(Reuters) – UnitedHealth has reached out to the U.S. Securities and Exchange Commission about billionaire investor Bill Ackman’s now-deleted post on social media platform X that said he would take a short position in the healthcare conglomerate.

WHY IT’S IMPORTANT

“If I still shorted stocks, I would short United Healthcare,” Ackman said in his post, referring to the company’s health insurance unit.

The investor also said the company’s profits are likely overstated due to its coverage decisions.

MARKET REACTION

UnitedHealth’s shares fell about 1.5% in afternoon trade after Ackman’s post.

KEY QUOTE

“Any claims that health insurers, which typically have low- to mid-single digit margins, can somehow over-earn are grossly uninformed about the structure and strong regulatory oversight of the sector,” a UnitedHealth spokesperson said.

The SEC declined to comment.

(Reporting by Christy Santhosh in Bengaluru)